Doc knocks DTC diagnostic ads

Writing in the December issue of Obstetrics & Gynecology, Dr. Erin Tracy said DTC ads for genetic tests are virtually unregulated and tests are costly and oft-misunderstood by consumers. Referring to the BracAnalysis ad campaign by Myriad Genetics, Tracy said: “Some patients with no risk factors for breast cancer come in and request the test for BRCA-1 and BRCA-2 mutations. The ads are compelling and they're emotionally driven. I end up spending time discussing why a particular test being advertised is not appropriate when I should be addressing important issues such as eating a healthy diet or smoking cessation.” 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions